CSNK2A3 and cancer: Our findings suggest that the aberrantly expressed transcript and/or protein of CK2α found in various cancer cells may be due to regulated CSNK2A3 (CK2αP) expression, which is potentially inducible or repressible by several master regulators of developmental pathways.